An AD animal model of AβPP transgenic mice, demonstrated that inflammation promoted Aβ deposition; an increased expression of β-site amyloid precursor protein cleaving enzyme 1 (BACE1) was associated with inflammation and this inflammation preceded Aβ deposition [245]. Here, APP is linked to Alzheimer disease.